Evaluation of the therapeutic activity of melatonin and resveratrol in Inflammatory Bowel Disease: A longitudinal PET/CT study in an animal model

Antioxidant activity applying an improved ABTS radical cation decolorization assay

Re, R., Pellegrini, N., Proteggente, A. R., Pannala, A. S., Yang, M. H., & Rice-Evans, C. A. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00315-3 · Cited by 26,298 · see citing works

Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases

Parada Venegas, D., De la Fuente, M. K., Landskron, G., González, M. J., Quera, R., Dijkstra, G., Harmsen, H. J. M., Faber, K. N., & Hermoso, M. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00277 · Cited by 3,820 · see citing works

Animal research: Reporting <i>in vivo</i> experiments: The ARRIVE guidelines

Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00872.x · Cited by 3,625 · see citing works

Hapten-Induced Model of Chronic Inflammation and Ulceration in the Rat Colon

Morris, G. P., Beck, P. L., Herridge, M. S., Depew, W. T., Szewczuk, M. R., & Wallace, J. L. (1989) · Gastroenterology · doi:10.1016/s0016-5085(89)80079-4 · Cited by 1,832 · see citing works

Chemically induced mouse models of acute and chronic intestinal inflammation

Wirtz, S., Popp, V., Kindermann, M., Gerlach, K., Weigmann, B., Fichtner-Feigl, S., & Neurath, M. F. (2017) · Nature Protocols · doi:10.1038/nprot.2017.044 · Cited by 1,575 · see citing works

Resveratrol: A Double-Edged Sword in Health Benefits

Salehi, B., Mishra, A. P., Nigam, M., Şener, B., Kılıç, M., Sharifi‐Rad, M., Fokou, P. V. T., Martins, N. A., & Sharifi‐Rad, J. (2018) · Biomedicines · doi:10.3390/biomedicines6030091 · Cited by 1,141 · see citing works

Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities

Hanauer, S. B. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000195385.19268.68 · Cited by 969 · see citing works

The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury

Langcake, P., & Pryce, R. J. (1976) · Physiological Plant Pathology · doi:10.1016/0048-4059(76)90077-1 · Cited by 912 · see citing works

Antioxidant properties of resveratrol: A structure–activity insight

Gülçın, İ. (2009) · Innovative Food Science & Emerging Technologies · doi:10.1016/j.ifset.2009.07.002 · Cited by 898 · see citing works

Development and validation of the Nancy histological index for UC

Bressenot, A., Salleron, J., Boulagnon‐Rombi, C., Bastien, C., Cahn, V., Cadiot, G., Diébold, M.-D., Danese, S., Reinisch, W., Schreiber, S., et al. (2015) · Gut · doi:10.1136/gutjnl-2015-310187 · Cited by 484 · see citing works

Effect of a Low Dose of Dietary Resveratrol on Colon Microbiota, Inflammation and Tissue Damage in a DSS-Induced Colitis Rat Model

Larrosa, M., Yañéz-Gascón, M. J., Selma, M. V., González-Sarrías, A., Toti, S., Cerón, J. J., Tomás-Barberán, F., Dolara, P., & Espín, J. C. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf803638d · Cited by 365 · see citing works

Mechanism of Action of Anti-TNF Therapy in Inflammatory Bowel Disease

Levin, A. D., Wildenberg, M. E., & BRINK, G. R. V. D. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw053 · Cited by 338 · see citing works

Anti-TNF Therapy in Crohn’s Disease

Adegbola, S. O., Sahnan, K., Warusavitarne, J. H., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082244 · Cited by 277 · see citing works

Conventional Medical Management of Inflammatory Bowel Disease

Burger, D. C., & Travis, S. P. L. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.045 · Cited by 252 · see citing works

Resveratrol and inflammatory bowel disease: the evidence so far

Nunes, S. P., Danesi, F., Rio, D. D., & Silva, P. (2017) · Nutrition Research Reviews · doi:10.1017/s095442241700021x · Cited by 236 · see citing works

The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model

Martín, A. R., Villegas, I., Sánchéz‐Hidalgo, M., & Alarcón‐de‐la‐Lastra, C. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706469 · Cited by 230 · see citing works

Resveratrol Suppresses Colitis and Colon Cancer Associated with Colitis

Cui, X., Yu, J. H., Hofseth, A. B., Peña, E. A., Habiger, J., Chumanevich, A. A., Poudyal, D., Nagarkatti, M., Nagarkatti, P. S., Singh, U. P., et al. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0117 · Cited by 219 · see citing works

Inflammatory bowel disease: exploring gut pathophysiology for novel therapeutic targets

Yadav, V., Varum, F., Bravo, R., Furrer, E., Bojic, D., & Basit, A. W. (2016) · Translational research · doi:10.1016/j.trsl.2016.04.009 · Cited by 168 · see citing works

Measurement of antioxidant ability of melatonin and serotonin by the DMPD and CUPRAC methods as trolox equivalent

Gülçın, İ. (2008) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756360701626223 · Cited by 167 · see citing works

Resveratrol attenuates high-fat diet-induced non-alcoholic steatohepatitis by maintaining gut barrier integrity and inhibiting gut inflammation through regulation of the endocannabinoid system

Chen, M., Hou, P., Zhou, M., Ren, Q., Wang, X., Huang, L., Hui, S., Yi, L., & Mi, M. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.05.020 · Cited by 148 · see citing works

Melatonin Reduces Inflammatory Injury through Inhibiting NF‐κB Activation in Rats with Colitis

Li, J., Yu, J., Yu, H., Xu, X., Yu, L.-L., Liu, J., & Luo, H.-S. (2005) · Mediators of Inflammation · doi:10.1155/mi.2005.185 · Cited by 139 · see citing works

Advances in rectal drug delivery systems

Purohit, T. J., Hanning, S. M., & Wu, Z. (2018) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2018.1484766 · Cited by 138 · see citing works

Melatonin reduces dinitrobenzene sulfonic acid‐induced colitis

Cuzzocrea, S., Mazzon, E., Serraino, I., Lepore, V., Terranova, M. L., Ciccolo, A., & Caputi, A. P. (2001) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2001.300101.x · Cited by 122 · see citing works

Effects of melatonin on the expression of iNOS and COX-2 in rat models of colitis

Dong, W. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i6.1307 · Cited by 110 · see citing works

New paradigms in chronic intestinal inflammation and colon cancer: role of melatonin

Motilva, V., García‐Mauriño, S., Talero, E., & Illanes, M. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00915.x · Cited by 106 · see citing works

PET/CT imaging of 3D printed devices in the gastrointestinal tract of rodents

Goyanes, Á., Fernández‐Ferreiro, A., Majeed, A., Gómez‐Lado, N., Awad, A., Luaces-Rodríguez, A., Gaisford, S., Aguiar, P., & Basit, A. W. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.11.055 · Cited by 105 · see citing works

Trans- but Not Cis-Resveratrol Impairs Angiotensin-II–Mediated Vascular Inflammation through Inhibition of NF-κB Activation and Peroxisome Proliferator-Activated Receptor-γ Upregulation

Rius, C., Abu-Taha, M. I., Hermenegildo, C., Piqueras, L., Cerdá‐Nicolás, M., Issekutz, A. C., Estañ, L., Cortijo, J., Morcillo, E. J., Orallo, F., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001043 · Cited by 96 · see citing works

Oxidative Stress and Effect of Treatment on the Oxidation Product Decomposition Processes in IBD

Dudzińska, E., Gryzińska, M., Ognik, K., et al. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/7918261 · Cited by 91 · see citing works

Differential immune and genetic responses in rat models of Crohn's colitis and ulcerative colitis

Shi, X.-Z. P., Winston, J. H., & Sarna, S. K. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00358.2010 · Cited by 83 · see citing works

Resveratrol and inflammatory bowel disease

Shi, Y., Zhou, J., Jiang, B., & Miao, M. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13426 · Cited by 72 · see citing works

Melatonin reduces colon immunological injury in rats by regulating activity of macrophages.

Mei, Q., Yu, J., Xu, J., et al. (2002) · PubMed · Cited by 67 · see citing works

Melatonin and ulcerative colitis: Evidence, biological mechanisms, and future research

Terry, P., Villinger, F. J., Bubenik, G. A., et al. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20527 · Cited by 60 · see citing works

Resveratrol Pretreatment Ameliorates TNBS Colitis in Rats

Yıldız, G., Yıldız, Y., Ulutaş, P. A., et al. (2015) · Recent Patents on Endocrine Metabolic & Immune Drug Discovery · doi:10.2174/1872214809666150806105737 · Cited by 60 · see citing works

Protective effect of melatonin in acetic acid induced colitis in rats

Nosál'ová, V., Zeman, M., Černá, S., Navarová, J., & Zakálová, M. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00428.x · Cited by 58 · see citing works

Melatonin, a Promising Supplement in Inflammatory Bowel Disease: A Comprehensive Review of Evidences

Mozaffari, S., & Abdollahi, M. R. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798999357 · Cited by 55 · see citing works

Change of nitric oxide in experimental colitis and its inhibition by melatonin in vivo and in vitro

Mei, Q., Xu, J.-M., Li, X., Hu, Y.-M., Hu, X.-P., & Xu, Z.-W. (2005) · Postgraduate Medical Journal · doi:10.1136/pgmj.2004.030817 · Cited by 52 · see citing works

Melatonin inhibits alcohol-induced increases in duodenal mucosal permeability in rats in vivo

Sommansson, A., Saudi, W. S. W., Nylander, O., & Sjöblom, M. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00074.2013 · Cited by 52 · see citing works

Alterations in melatonin and 5‐HT signalling in the colonic mucosa of mice with dextran‐sodium sulfate‐induced colitis

MacEachern, S. J., Keenan, C. M., Papakonstantinou, E., Sharkey, K. A., & Patel, B. A. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14163 · Cited by 37 · see citing works

Mucoadhesive properties of cross-linked high amylose starch derivatives

Mulhbacher, J., Ispas‐Szabo, P., Ouellet, M., et al. (2006) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2006.05.003 · Cited by 30 · see citing works

A Review of the Use of Melatonin in Ulcerative Colitis

Jena, G., & Trivedi, P. P. (2013) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000436962.32164.6e · Cited by 29 · see citing works

Longitudinal PET/CT evaluation of TNBS-induced inflammatory bowel disease rat model

Seoane‐Viaño, I., Gómez‐Lado, N., Lázare‐Iglesias, H., Acosta, M. B., Silva‐Rodríguez, J., Álvarez, A. L., Herranz, M., Otero-Espinar, F. J., López, J. R. A., Lamas, M. J., et al. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.08.005 · Cited by 20 · see citing works

Development, Characterization, and In Vitro Evaluation of Resveratrol-Loaded Poly-(ε-caprolactone) Microcapsules Prepared by Ultrasonic Atomization for Intra-Articular Administration

Álvarez, A. L., Lamela-Gómez, I., Otero-Espinar, F. J., & Blanco-Méndez, J. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11060249 · Cited by 20 · see citing works

Efficacy of budesonide-loaded mesoporous silica microparticles capped with a bulky azo derivative in rats with TNBS-induced colitis

Ferri, D., Costero, A. M., Gaviña, P., et al. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.02.030 · Cited by 19 · see citing works

Vaginal residence and pharmacokinetic preclinical study of topical vaginal mucoadhesive W/S emulsions containing ciprofloxacin

Campaña-Seoane, M., Pérez-Gago, A., Vázquez, G., et al. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.11.022 · Cited by 15 · see citing works

Molecular Imaging in Preclinical Models of IBD with Nuclear Imaging Techniques

Kaaru, E., Bianchi, A., Wunder, A., Rasche, V., & Stiller, D. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000904 · Cited by 13 · see citing works

Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements

Minich, D. M., Henning, M., Darley, C., Fahoum, M., Schuler, C. B., & Frame, J. (2022) · Nutrients · doi:10.3390/nu14193934 · Cited by 176 · see citing works

Loss of response to melatonin treatment is associated with slow melatonin metabolism

Braam, W., Van Geijlswijk, I., Keijzer, H., Smits, M. G., Didden, R., & Curfs, L. M. G. (2010) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2010.01283.x · Cited by 94 · see citing works

The Effects of Melatonin Treatment on Oxidative Stress Induced by Ovariohysterectomy in DogsPreprint

Salavati, S., Mogheiseh, A., Nazıfı, S., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-123019/v1 · Cited by 3 · see citing works

Resveratrol: Biochemistry and Functions

Das, S., Vasanthi, H. R., & Das, D. K. (2009) · doi:10.1002/9780470531792.ch14 · Cited by 2 · see citing works

Serum melatonin levels in melanoma patients after repeated oral administration

Kane, M. A., Johnson, A., Nash, A., Boose, D., Mathai, G., Balmer, C. M., Yohn, J. J., & Robinson, W. A. (1994) · Melanoma Research · doi:10.1097/00008390-199402000-00009 · Cited by 9 · see citing works

Are the proposed benefits of melatonin-rich foods too hard to swallow?

Kennaway, D. J. (2015) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2014.962686 · Cited by 33 · see citing works